Oxford Academic Health Science Network

The creation of the Oxford Academic Health Science Network (the Network) is an outstanding opportunity for all partners working in these sectors to come together with commissioning bodies, patients and the public to form a community to participate in providing evidence based best care for our patients and population, to innovate and in so doing, to deliver new opportunities to create wealth.

Find out more at https://www.oxfordahsn.org/

For further information please contact: Megan Turmezei, Assistant Director, Special Projects, Planning and Information/AHSN Project Manager 01865 572788 megan.turmezei@ouh.nhs.uk

The Oxford Academic Health Science Network is composed of

  • health and social care providers
  • NHS commissioners
  • universities
  • life sciences industry and business and commercial organisations, and
  • constituent population within Berkshire, Buckinghamshire (including Milton Keynes) and Oxfordshire – The Thames Valley – and Bedfordshire.

Its NHS affiliates provide links into the following areas

  • Gloucestershire
  • South Warwickshire
  • Northamptonshire and
  • Wiltshire

These affiliates reflect existing and long standing clinical networks. The population served will be 3.3 million, which is predicted to grow significantly in some areas including Milton Keynes.

Membership currently includes

  • all NHS trusts and commissioners
  • all NIHR bodies
  • all universities
  • a range of NHS related bodies including
    • Solutions for Public Health
    • Patient Safety Federation
    • UK Cochrane Centre
    • the National Spinal Injuries Centre
    • NHS Innovations SE
    • a number of local authorities



The Network will deliver best care through a sustainable population-centred system that ensures equity of access for our patients using continuous learning and the research-focused Network, which leads to new opportunities to create wealth by healthcare innovation.


Goal 1: To deliver best care in a population-centred healthcare system: To identify and address unwarranted variation by disseminating evidence-based best practice, making the patient and the population at the centre of care.

Goal 2: To develop an effective continuous learning network: To create a genuine partnership that develops a culture of learning, sharing and common purpose, which breaks down organisational boundaries to deliver transformational change.

Goal 3: To complete the translational research process and accelerate the diffusion of innovation into mainstream practice: To align and integrate clinical service and the translational research infrastructures to bring rapid benefits to patients and deliver NIHR priorities.

Goal 4: To tackle local priorities: which include long-term conditions, mental health conditions and the development of new approaches in medicine, such as genomic medicine.

Goal 5: To facilitate sustainable economic development and wealth creation in alignment with best care: To grow local life sciences clusters by promoting innovation, adoption and dissemination, entrepreneurship and by strengthening relationships with industry and business.